{"schema_version":"secwatch.filing_event.v1","accession":"0001789769-24-000070","form_type":"8-K","ticker":"TIL","cik":"0001789769","company_name":"Instil Bio, Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.126313+00:00","generated_at":"2026-06-01T04:08:56.595228+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Instil Bio stockholders elect two directors, ratify auditor at 2024 annual meeting","bullets":["R. Kent McGaughy, Jr. elected as Class III director with 4,499,758 votes for and 129,194 withheld.","Dr. Gwendolyn Binder elected as Class III director with 4,351,989 votes for and 276,963 withheld.","Stockholders ratified Deloitte & Touche as auditor for FY 2024: 5,718,919 for, 11,543 against, 6,627 abstentions.","Approximately 88.20% of outstanding shares (5,737,089 of 6,503,913) were present or represented by proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0001789769-24-000070","json":"https://secwatch.observer/filing/0001789769-24-000070.json","markdown":"https://secwatch.observer/filing/0001789769-24-000070.md","text":"https://secwatch.observer/filing/0001789769-24-000070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789769/000178976924000070/0001789769-24-000070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789769/000178976924000070/til-20240613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:08:56.595228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}